Trial intelligence / Profile preview

UK-369,003 MR in men with storage lower urinary tract symptoms with and without erectile dysfunction

2006-006656-35Phase 2Completed

Sponsor
Pfizer
Start
Apr 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in overactive bladder (OAB), Micturition disorder and erectile dysfunction (ED) comparing UK-369,003 MR with Placebo (2 arms). Primary endpoint: Primary: LUTS diary outcomes. Started Apr 2007; status: completed.

02

Drugs

gisadenafil
03

Conditions

overactive bladder (OAB)Micturition disordererectile dysfunction (ED)

Beyond the preview

Go deeper on 2006-006656-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-006656-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call